Related Experiment Video
Updated: Jul 25, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Maternal and Child Health, Non-Communicable Diseases and Metabolites
1Grants, Innovation and Product Development, South African Medical Research Council, P.O. Box 19070, Tygerberg, Cape Town 7505, South Africa.
Insights
Maternal metabolites significantly impact child health and disease risk. Understanding these metabolic influences offers new avenues for preventing non-communicable diseases in mothers and children.
Area of Science:
- Maternal-fetal and lactational-neonatal health
- Metabolomics and non-communicable diseases
Background:
- Maternal health critically influences child development and long-term disease trajectories.
- Metabolites act as key mediators between maternal environment and offspring health outcomes.
- Non-communicable diseases (NCDs) like diabetes and cardiovascular disease are increasingly prevalent and linked to maternal and child health.
Purpose of the Study:
- To explore the role of maternal metabolites in shaping child health and disease.
- To identify metabolite profiles that predict NCD onset in mothers and children.
- To leverage metabolic insights for improved maternal and child health strategies.
Main Methods:
- Analysis of maternal and child metabolite profiles.
- Correlation of metabolite variations with health and disease outcomes.
- Investigation of metabolite impact on physiological systems and signaling pathways.
Main Results:
- Metabolite aberrations are linked to physiological changes and dietary influences.
- Differential metabolite profiles can predict NCD development.
- Maternal metabolic milieu significantly shapes progeny health and disease susceptibility.
Conclusions:
- Understanding maternal-child metabolite interplay is crucial for lifelong health.
- Metabolites offer potential as biomarkers for NCD prevention and treatment.
- Targeting metabolic pathways presents opportunities for novel therapeutic interventions in maternal and child health.
Abstract:
Mothers influence the health and disease trajectories of their children, particularly during the critical developmental windows of fetal and neonatal life reflecting the gestational-fetal and lactational-neonatal phases. As children grow and develop, they are exposed to various stimuli and insults, such as metabolites, that shape their physiology and metabolism to impact their health. Non-communicable diseases, such as diabetes, cardiovascular disease, cancer and mental illness, have high global prevalence and are increasing in incidence. Non-communicable diseases often overlap with maternal and child health. The maternal milieu shapes progeny outcomes, and some diseases, such as gestational diabetes and preeclampsia, have gestational origins. Metabolite aberrations occur from diets and physiological changes. Differential metabolite profiles can predict the onset of non-communicable diseases and therefore inform prevention and/or better treatment. In mothers and children, understanding the metabolite influence on health and disease can provide insights for maintaining maternal physiology and sustaining optimal progeny health over the life course. The role and interplay of metabolites on physiological systems and signaling pathways in shaping health and disease present opportunities for biomarker discovery and identifying novel therapeutic agents, particularly in the context of maternal and child health, and non-communicable diseases.
Related Concept Videos
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Regulation of Metabolism
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Diabetes Mellitus: Type 2 and Gestational
Drug Metabolism: Phase II Reactions
Teratogenicity

